Improving Patient Reported Outcome Measures in Catheter Ablation
Use of Patient Reported Outcome Measures (PROMs) to Assess Quality of Life and Economic Evaluation of Cardiac Catheter Ablation of Ventricular Tachycardia: a Feasibility and Cohort Study
Barts & The London NHS Trust
70 participants
Jun 13, 2024
INTERVENTIONAL
Conditions
Summary
This study will assess whether more frequent measurement of patient reported outcome measures (PROMs) - specifically health related quality of life (HRQL) - can improve the evaluation of the clinical effectiveness and cost-effectiveness of catheter ablation of ventricular tachycardia (VT) in patients with an Implantable Cardioverter Defibrillator (ICD). It is designed to have feasibility outcomes which contribute to answering the above.
Eligibility
Inclusion Criteria2
- Adults (\>18 years) With an Implantable Cardioverter Defibrillator (ICD) implanted \>3 months from time of recruitment and a previous episode of documented VT requiring therapy from the ICD.
- And impaired LV/RV function Willing and able to give written informed consent
Exclusion Criteria1
- Patients who are planning to move away from study site within 12 months of enrolment who wished to use postal method to complete their HRQL Patients who are unable to give informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patient quality of life to be assessed at baseline, 1, 2, 3, 4, 6, 9 and 12 months
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04499326